-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
-
Summary
-
Ionis Pharmaceuticals Inc quarterly/annual Amortization of Intangible Assets history and growth rate from 2016 to Q1 2025.
- Ionis Pharmaceuticals Inc Amortization of Intangible Assets for the quarter ending March 31, 2025 was $582K, a 8.92% decline year-over-year.
- Ionis Pharmaceuticals Inc annual Amortization of Intangible Assets for 2024 was $2.34M, a 8.71% decline from 2023.
- Ionis Pharmaceuticals Inc annual Amortization of Intangible Assets for 2023 was $2.56M, a 5.96% increase from 2022.
- Ionis Pharmaceuticals Inc annual Amortization of Intangible Assets for 2022 was $2.42M, a 2.68% increase from 2021.
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Amortization of Intangible Assets, Annual (USD)
Amortization of Intangible Assets, YoY Annual Growth (%)